|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
134,746,000 |
Market
Cap: |
1.57(B) |
Last
Volume: |
3,983,089 |
Avg
Vol: |
3,971,973 |
52
Week Range: |
$10.31 - $14.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 457 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
20,526 |
71,026 |
3,241,429 |
7,930,135 |
Total Sell Value |
$262,322 |
$986,072 |
$41,921,797 |
$106,117,062 |
Total People Sold |
1 |
3 |
4 |
6 |
Total Sell Transactions |
1 |
5 |
18 |
31 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Burgess Justin |
Chief Accounting Officer |
|
2023-08-07 |
4 |
S |
$14.55 |
$117,247 |
D/D |
(8,061) |
0 |
|
9% |
|
Burgess Justin |
Chief Accounting Officer |
|
2023-08-07 |
4 |
OE |
$5.42 |
$65,767 |
D/D |
8,061 |
8,061 |
|
- |
|
Hack Andrew A. F. |
Director |
|
2023-06-14 |
4 |
S |
$12.68 |
$6,340,000 |
I/I |
(500,000) |
2,415,000 |
|
-9% |
|
Paradiso Peter R. |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
13,714 |
|
- |
|
Sun Elaine D |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
18,750 |
|
- |
|
Macgregor Brent |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
10,714 |
|
- |
|
Eastland Julia Marie |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
10,714 |
|
- |
|
Cano Francis |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
31,548 |
|
- |
|
Myers Scott Dunseth |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
20,089 |
|
- |
|
Phillips Peggy V |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
38,447 |
|
- |
|
Kisner Daniel L |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
12,214 |
|
- |
|
Hack Andrew A. F. |
Director |
|
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,357 |
10,714 |
|
- |
|
Hack Andrew A. F. |
Director |
|
2023-05-18 |
4 |
S |
$10.55 |
$10,550,000 |
I/I |
(1,000,000) |
2,915,000 |
|
-32% |
|
Novack David F |
President & COO |
|
2023-05-04 |
4 |
S |
$10.90 |
$190,914 |
D/D |
(17,515) |
3,187 |
|
-25% |
|
Macdonald Kelly |
SVP and CFO |
|
2023-02-27 |
4 |
D |
$10.36 |
$30,821 |
D/D |
(2,975) |
2,359 |
|
- |
|
Macdonald Kelly |
SVP and CFO |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,334 |
5,334 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2023-02-27 |
4 |
S |
$10.32 |
$232,146 |
D/D |
(22,371) |
0 |
|
-22% |
|
Burgess Justin |
Chief Accounting Officer |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,250 |
12,538 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2023-02-27 |
4 |
D |
$10.36 |
$310,593 |
D/D |
(29,980) |
178,459 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,472 |
193,132 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-02-27 |
4 |
D |
$10.36 |
$74,343 |
D/D |
(7,176) |
49,925 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,584 |
51,706 |
|
- |
|
Novack David F |
President & COO |
|
2023-02-27 |
4 |
D |
$10.36 |
$182,015 |
D/D |
(17,569) |
20,702 |
|
- |
|
Novack David F |
President & COO |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,084 |
29,292 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2023-02-15 |
4 |
A |
$9.73 |
$17,378 |
D/D |
1,786 |
147,967 |
|
- |
|
423 Records found
|
|
Page 3 of 17 |
|
|